Tyler R. Simpson, Ph.D.

2013 Weill Cornell Medical College, New York, NY, United States 
Immunology, Oncology, Cell Biology
"Tyler Simpson"
Mean distance: (not calculated yet)


Sign in to add mentor
James Patrick Allison grad student 2013 Weill Cornell Medical College
 (Defining the impact of CTLA-4 blockade immunotherapy and the tumor microenvironment on the anti-tumor activity of the CD4+ T cell compartment.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hanson A, Elpek K, Duong E, et al. (2020) ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models. Plos One. 15: e0239595
Elpek K, Harvey C, Duong E, et al. (2016) Abstract A059: Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics Cancer Immunology Research. 4
LeBleu VS, Özdemir BC, Pentcheva-Hoang T, et al. (2016) Abstract IA15: Functional diversity of the pancreas tumor stroma Cancer Research. 76
Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. (2015) Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. Cancer Cell. 28: 831-833
Pentcheva-Hoang T, Simpson TR, Montalvo-Ortiz W, et al. (2014) Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility. Cancer Immunology Research. 2: 970-80
Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. (2014) Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 25: 719-34
Simpson TR, Li F, Montalvo-Ortiz W, et al. (2013) Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. The Journal of Experimental Medicine. 210: 1695-710
Quezada SA, Peggs KS, Simpson TR, et al. (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunological Reviews. 241: 104-18
Quezada SA, Simpson TR, Peggs KS, et al. (2010) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. The Journal of Experimental Medicine. 207: 637-50
Simpson TR, Quezada SA, Allison JP. (2010) Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Current Opinion in Immunology. 22: 326-32
See more...